Vaccine Effectiveness Study

Monitoring the vaccine’s effectiveness and impact is crucial to know the immediate and long-term effects, as many questions remain unanswered in clinical trials.

Instituto Gulbenkian de Ciência has been developing several monitoring studies in different age groups of the population and of different vaccines available in the country, in partnership with hospitals, health agencies and municipalities. INFO-VAC intends to study the SARS-CoV-2 vaccine effectiveness.

The set of data collected will be shared with the National Health Institute Dr. Ricardo Jorge, which will speed up, with European Agencies (ECDC), the extended national monitoring which will allow to provide information for possible updates of the global policy recommendations.


INFO-VAC Healthcare Professionals 

Study follows up 1250 healthcare professionals from Centro Hospitalar Lisboa Central E.P.E. 

INFO-VAC Oeiras Schools

Study follows up teaching and non teaching staff from several schools from Oeiras Municipality.

INFO-VAC Elderly

Study follows-up 260 elderly living in nursing homes.

INFO-VAC Cancer Patients

Study follows up 211 cancer patients from the Hospital Professor Doutor Fernando Fonseca.

Updated on 20 october 2021

Cookies settings

Cookies Selection

The Calouste Gulbenkian Foundation uses cookies to improve your browsing experience, security, and its website performance. The Foundation may also use cookies to share information on social media and to display messages and advertisements personalised to your interests, both on our website and in others.